While inflation and economic pressures force pharmaceutical brands to watch their pennies, they will do well to not tackle cost efficiency as a solo issue. Brands require resilience in various areas, and chief among these is compliance. Stringent regulations must be followed, although the supply chains from which they are navigated, are incredibly complex.
So, can brands manage resilience factors, such as costs and compliance, holistically?
Posted in
(Data and Information Governance (DIG)) In Part One we looked at how the advent of lawsuits surrounding indirect access could well lead to significant changes in the world of today’s software solutions. As software companies focus on niches and providing expertise in particular sectors, the all in one ERP solutions are looking more and more […]
Business ProcessesGeneralHICXMaster Data Management Read now“A groundbreaking partnership with a new vision for renewable data and intelligent applications” – that’s how Microsoft, Adobe and SAP have described their new pact, the Open Data Initiative. Their collective goal is clear – allow data to be stored centrally on one platform and then exchanged smoothly between each company’s systems – but the […]
Business ProcessesMaster Data ManagementSupplier Onboarding Read now
